טוען...
Ribavirin for Chronic Hepatitis Prevention among Patients with Hematologic Malignancies
Findings among a cohort of 26 patients who had hematologic malignancies and hepatitis E virus (HEV) infection support that HEV can induce chronic hepatitis. However, a 3-month course of ribavirin can induce a rapid viral clearance, reducing the risk for chronic hepatitis and enabling continuation of...
שמור ב:
| הוצא לאור ב: | Emerg Infect Dis |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Centers for Disease Control and Prevention
2015
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4517705/ https://ncbi.nlm.nih.gov/pubmed/26197210 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3201/eid2108.150199 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|